FHC Group
Marta Canelas is a highly experienced professional in pharmacovigilance, currently serving as Pharmacovigilance Manager since February 2020 at FHC Group and holding multiple titles including EU-QPPV and Deputy EU-QPPV at Phagecon - Pharmaceutical Services and Consulting. Marta has also worked as a Pharmacovigilance Officer at both Viatris and Pharsolution, gaining significant expertise in the field. Prior roles include Quality, Vigilance, Medical Information and Regulatory Affairs Trainee at Pierre Fabre Group, Quality Assurance Trainee at GSK, and various pharmacist positions during training at reputable hospitals and pharmacies. Marta holds a degree from the Faculty of Pharmacy of the University of Lisbon and a post-graduate qualification in Medical Science Liaison from Universidade Católica Portuguesa.
FHC Group
The FHC Group is one of the most relevant business groups in the pharmaceutical area in Portugal, present in all sectors of Pharma value chain of medicines, with recognized specialization and recognition in the industrial area, distribution in the retail pharmacy and hospital market, export and internationalization, R&D as well as in the pharmaceutical consultancy area. The FHC group begins its foundation with the creation of the company “FHC | Farmacêutica” in 1998, dedicated to the international market. After consolidates its position in the pharmaceutical industrial sector with the acquisition and dynamization of Basi laboratories in 2003. The FHC Group is a Portuguese multinational with origin and capital exclusively private and present in 4 continents.